Heba Ahmed Almokadem

Heba Ahmed Almokadem

Auto-generated profile, based on publicly available information

Heba Ahmed Almokadem

Rheumatology, Rehabilitation, and Physical Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Marwa BadrMarwa Badr
Marwa Badr
GAGellan Ahmed
Gellan Ahmed
RAReham A. Amer
Reham A. Amer
HAHend M. Aref
Hend M. Aref
RSRehab M. Salem
Rehab M. Salem
EKEman M Khedr
Eman M Khedr
Few randomized controlled trials have reported that repetitive transcranial magnetic stimulation (rTMS) has controversial results for managing multiple domains of fibromyalgia-related symptoms. This work aimed to evaluate the effect of low-frequency rTMS over the right dorsolateral prefrontal area (DLPFC) on the Fibromyalgia Impact Questionnaire (FIQ) concerning psychiatric and cognitive disorders. Forty-two eligible patients with fibromyalgia (FM) were randomized to have 20 sessions of active or sham rTMS (1 Hz, 120% of resting motor threshold with a total of 1200 pules/session) over the right DLPFC. All participants were evaluated at baseline, post sessions, and 3 months after sessions with the FIQ, Hamilton depression, and anxiety rating scales (HDRS and HARS), Montreal Cognitive Assessment (MoCA), Rey Auditory Verbal Learning Test (RAVLT), Tower of London test (TOL), the Trail Making, and Digit Span Tests. Both groups showed improvement in most rating scales at 1 and 3 months follow-up, with greater improvement in the active group, with significant correlation between FIQ cognitive rating scales, including RAVLT and TOL. Twenty sessions of low-frequency rTMS over the right DLPFC can improve FIQ scores regarding the psychiatric and cognitive symptoms of medicated patients with FM to a greater extent than sham. Changes in RAVLT and TOL correlated with changes in FIQ results.

31 December 2023 in Sleep Medicine Research
Verified
Journal Article
Open access
PDF file
Marwa BadrMarwa Badr
Marwa Badr
AEAmira A. Elkholy
Amira A. Elkholy
SASheren D. Abohamer
Sheren D. Abohamer
SSSara M. Shoeib
Sara M. Shoeib
RSRehab M. Salem
Rehab M. Salem
AEAhmed Elsharkawy
Ahmed Elsharkawy
Background and Objective The precise pathophysiology of cognitive impedance and mental illness in obstructive sleep apnea (OSA) patients remains elusive. Therefore, there is a need for studies on novel diagnoses and therapeutic strategies for cognitive impairment in OSA patients. This work aimed to evaluate cerebral hypoxemia, its consequences on brain metabolism, and local and systemic inflammation, and their subsequent impact on cognitive and psychological functioning.Methods This cross-sectional case-control study was conducted on 30 eligible OSA patients and 20 age/sex-matched healthy controls. All the participants underwent one-night polysomnography, and cognitive evaluation was done using the Mini-Mental State Examination, Montreal Cognitive Assessment, Brief Kingston Standardized Cognitive Assessment, D2 Test of Consideration (to evaluate attention problems), and Wisconsin card sorting test. The psychiatric assessment included the Arabic form of the Hamilton Depression Rating Scale and Beck Depression Inventory-II. A radiology assessment was done using proton magnetic resonance spectroscopy. Neurophysiological assessment was done using the potential cortical (N20) latency and amplitude of somatosensory evoked potential. Laboratory examinations included serum levels of NF-κB, HMGB1, and HIF-1α.Results Polysomnography demonstrated noteworthy increase in the apnea-hypopnea index, respiratory disturbance index, arousal index, snoring index, and wake after sleep onset. It also showed diminished sleep efficiency, total sleep time, and SaO2 nadir in the OSA group. Neuropsychological scales demonstrated poor performance in global cognitive tests, particular cognitive domains impedance, and depression in the OSA group, with noteworthy differences within the group. Magnetic resonance spectroscopy highlighted that OSA patients had a noteworthy bilateral decrement in N-acetylaspartate (NAA) peak, creatine peak, and NAA/choline proportion and an increment in choline peak, lipid peak, lactate peak, choline/creatine proportion, and NAA/creatine proportion in the frontal white matter, hippocampus, and parieto-occipital cortex. Moreover. OSA patients had either missing or decreased amplitude and delayed latency of N20. There was a noteworthy rise of serum inflammatory marker NF-κB, HMGB1, and oxidative stress marker HIF-1α in OSA patients.Conclusions Chronic intermittent hypoxia with resulting amplified inflammatory and oxidative stress in OSA patients may affect brain metabolism; consequently, leading to cognitive and psychological dysfunctions.

10 April 2025 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
ASAmira Mohamed El Sharkawy
Amira Mohamed El Sharkawy
RERania Elsaied Elkholy
Rania Elsaied Elkholy
HAHeba Ahmed Almokadem
Heba Ahmed Almokadem
Background: Rheumatoid arthritis (RA) patients are at risk of malnutrition and physical inactivity, in particular elderly patients (≥ 65 years). This study aimed to evaluate the nutritional status and physical activity (PA) level in a sample of elderly RA patients and their correlation to functional capability and disease activity. The study included 100 RA patients and 100 apparently healthy volunteers as a control group of matching age and sex. All the participants were assessed for their nutritional status using the Mini Nutritional Assessment Short Form (MNA-SF) and body composition through electrical bioimpedance. PA level was assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF). Results: There was a statistically significant difference between RA patients and the control group regarding fat mass (36.10 ± 5.93% vs 30.90 ± 7.95%; p = 0.0.034) and lean mass (21.73 ± 9.49 kg vs 29.90 ± 10.42 kg; p = 0.027) with RA patients had higher fat mass but lower lean mass than controls. For the nutritional status assessed by MNA-SF, there was a statistically significant difference between RA patients and the control group (11.57 ± 1.28 vs 13.70 ± 0.48; p = < 0.001) with (50%) of RA patients while only (4%) of the control group were at malnutrition risk. None of the participants were undernourished. There was a statistically significant difference between RA patients and the control group regarding PA assessed by IPAQ-SF (p = 0.007) with (50%) of RA patients having low, whereas (50%) of the control group had high IPAQ-SF. There was a highly significant negative correlation of MNA-SF with laboratory markers of inflammatory activity, different activity indices, and functional capability assessed by a modified health assessment questionnaire (MHAQ). Fat mass was positively correlated with age, while skeletal muscle mass and PAQ-SF were negatively correlated with MHAQ. Conclusion: Elder patients with RA are more prone to impaired nutritional status either malnutrition or risk of malnutrition assessed by MNA and low PA levels assessed by IPAQ-SF. Moreover, they have higher fat mass but lower lean mass than controls as evaluated by electrical bioimpedance. In elder patients with RA, nutritional status is negatively correlated with laboratory markers of inflammatory activity, different activity indices, and functional impairment, whereas reduced PA levels are correlated with functional impairment.

3 July 2026 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
RERania Elsaied Elkholy
Rania Elsaied Elkholy
ASAmira Mohamed El Sharkawy
Amira Mohamed El Sharkawy
HHHala Ibrahim Hantash
Hala Ibrahim Hantash
EEEman Mohamed Elaskary
Eman Mohamed Elaskary
HSHeba Mohamed Shafik
Heba Mohamed Shafik
HAHeba Ahmed Almokadem
Heba Ahmed Almokadem
Juvenile systemic lupus erythematosus (JSLE) represents a severe chronic multisystem autoimmune inflammatory disease that typically manifests prior to 18 years of age, exhibiting peak incidence at ...

2 December 2025 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
SEShereen Abdelsalam Elwan
Shereen Abdelsalam Elwan
HHHala Ibrahim Mohamed Hantash
Hala Ibrahim Mohamed Hantash
AEAmany Elbarky
Amany Elbarky
HHHeba Abd EL Aziz Hashim
Heba Abd EL Aziz Hashim
HAHeba Ahmed Almokadem
Heba Ahmed Almokadem
Objective: The specific carbohydrate diet (SCD) has demonstrated a beneficial effect in pediatric inflammatory bowel disease. This study aimed to determine the potential effect of a minimum 4-week SCD intervention on children with juvenile idiopathic arthritis (JIA). Methods: This prospective, single-arm, interventional pilot study encompassed 40 patients with JIA exhibiting mild to moderate disease activity as per juvenile arthritis disease activity score-27(JADAS27), with ≤ 2 active joints, and an erythrocyte sedimentation rate (ESR) of < 30 mm/h at inclusion. Participants were required to have maintained stable medical treatment without any modifications for a minimum of 12 weeks prior to enrollment, with no anticipated alterations in medication during the study duration. Patients adhered to the SCD for at least 4- week duration under the guidance of a pediatric dietitian. Of the 40 JIA patients incorporated into the study, only 27 patients aged 9–16 years with disease duration of 1-11years completed a minimum 4 weeks adherence to the SCD. Evaluation of morning stiffness duration, pain visual analogue scale (VAS), JADAS27 and physical functional evaluation using child health assessment questionnaire (CHAQ) were determined. Laboratory assessments, including ESR and C-reactive protein (CRP) were analyzed. Furthermore, Faecal Short-Chain Fatty Acids (SCFAs) including butyrate, propionate, acetate, and valerate, were measured. All evaluations were conducted at baseline and subsequent to a minimum of four weeks of adherence to the SCD. Results: Regarding the evaluation of SCFAs, butyrate levels demonstrated a significant increase ( p < 0.001) following the SCD intervention. Propionate and acetate, while also elevated ( p = 0.004 and 0.01 respectively), displayed a less substantial increase in comparison to butyrate. Valerate likewise showed a significant increase ( p = 0.048). These elevations in SCFAs coincided with a significant improvement in morning stiffness duration ( p = 0.016), pain VAS, JADAS27, and CHAQ ( p < 0.001 for all), which was further corroborated by a significant decrease in laboratory markers of inflammation, including ESR ( p = 0.009) and CRP ( p = 0.006). Conclusion: Specific carbohydrate diet, as a prospective adjunctive therapeutic option, could potentially improve clinical outcomes in JIA patients. While the positive preliminary findings, it is essential to conduct more rigorous and controlled studies to validate these results.

19 August 2026 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
RSRehab Mahmoud Salem
Rehab Mahmoud Salem
HAHeba Ahmed Almokadem
Heba Ahmed Almokadem
RERania Elsaied Elkholy
Rania Elsaied Elkholy
TMThanaa F. Mansour
Thanaa F. Mansour
YRYousra Fouad Mohamed Rashad
Yousra Fouad Mohamed Rashad
RSRadwa H Shalaby
Radwa H Shalaby
Objectives: To evaluate the effect of anti-tumor necrosis factor (anti-TNF) therapy on thyroid gland functionality and morphological characteristics in anti-TNF naïve psoriatic arthritis (PsA) patients. Methods: 60 adult patients with PsA were included in a prospective study, all exhibiting moderate to severe disease activity as per Disease Activity in Psoriatic Arthritis (DAPSA) score despite conventional therapy and were subsequently planned to initiate biological therapy as part of standard clinical management. Patients were anti-TNF naïve at enrollment. Thyroid stimulating hormone (TSH), free T3 and T4 were measured, alongside anti-thyroid peroxidase (ATPO) and anti-thyroglobulin (ATG) antibodies. Thyroid gland morphology was determined through ultrasonography. All evaluations were conducted at baseline and following 6 months of anti-TNF therapy. Results: At baseline, all PsA patients demonstrated normal thyroid function (TSH, free T3, and T4). Six months of anti-TNF therapy yielded no substantial alterations in thyroid function, with only a minor reduction in TSH observed (2.28 ± 1.14 vs. 2.12 ± 1.01). Thyroid auto-antibodies were positive in 6 patients (10%) at baseline and remained positive after treatment, along with modest, statistically non-significant reductions in the mean serum levels: ATPO antibodies (36.93 ± 46.59 vs. 31.93 ± 38.65), ATG antibodies (68.06 ± 45.44 vs. 66.70 ± 61.25). Baseline ultrasound evaluation revealed subclinical changes, with all findings demonstrating trivial non-significant changes after anti-TNF therapy. Conclusion: Anti-TNF naïve patients with PsA exhibiting baseline thyroid autoantibody positivity and ultrasound changes demonstrated a statistically non-significant decline subsequent to 6 months of anti-TNF therapy.